Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penny L Moore

Showing results (61-70 of 215) with videos related to

Pageof 22
Sort By:
Journal of Virology|June 24, 2011
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding siteKabamba Bankoledi Alexandre, Elin S Gray, Ralph Pantophlet, et al.
Plos One|December 18, 2018
The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256Michiel T van Diepen, Rosamund Chapman, Penny L Moore, et al.
Vaccines|November 27, 2021
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIVRos Chapman, Michiel van Diepen, Nicola Douglass, et al.
AIDS (London, England)|June 11, 2021
Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccinationEunice W Nduati, Mathew J Gorman, Yiakon Sein, et al.
Virology|June 10, 2008
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralizationEmma T Crooks, Pengfei Jiang, Michael Franti, et al.
Virology|July 17, 2007
Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodiesCecilia Rademeyer, Penny L Moore, Natasha Taylor, et al.
AIDS Research and Therapy|April 6, 2025
Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV - a reviewSharana Mahomed, Kayla Pillay, Razia Hassan-Moosa, et al.
Virology|October 1, 2013
Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVNKabamba B Alexandre, Penny L Moore, Molati Nonyane, et al.
AIDS Research and Human Retroviruses|May 19, 2006
Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progressionIsaac Choge, Tonie Cilliers, Polly Walker, et al.
Journal of Virology|February 15, 2019
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting VirusMichiel T van Diepen, Rosamund Chapman, Nicola Douglass, et al.
Pageof 22

Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Journal of Virology|June 24, 2011
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding siteKabamba Bankoledi Alexandre, Elin S Gray, Ralph Pantophlet, et al.
Plos One|December 18, 2018
The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256Michiel T van Diepen, Rosamund Chapman, Penny L Moore, et al.
Vaccines|November 27, 2021
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIVRos Chapman, Michiel van Diepen, Nicola Douglass, et al.
AIDS (London, England)|June 11, 2021
Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccinationEunice W Nduati, Mathew J Gorman, Yiakon Sein, et al.
Virology|June 10, 2008
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralizationEmma T Crooks, Pengfei Jiang, Michael Franti, et al.
Virology|July 17, 2007
Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodiesCecilia Rademeyer, Penny L Moore, Natasha Taylor, et al.
AIDS Research and Therapy|April 6, 2025
Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV - a reviewSharana Mahomed, Kayla Pillay, Razia Hassan-Moosa, et al.
Virology|October 1, 2013
Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVNKabamba B Alexandre, Penny L Moore, Molati Nonyane, et al.
AIDS Research and Human Retroviruses|May 19, 2006
Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progressionIsaac Choge, Tonie Cilliers, Polly Walker, et al.
Journal of Virology|February 15, 2019
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting VirusMichiel T van Diepen, Rosamund Chapman, Nicola Douglass, et al.
Pageof 22